or Try an Advanced Search...

    Technical Analysis for NEXI - NexImmune, Inc.

    Grade Last Price % Change Price Change
    F 3.38 -5.85% -0.21
    NEXI closed down 5.85 percent on Wednesday, May 8, 2024, on 40 percent of normal volume.
    Earnings due: May 13
    *** please verify all earnings dates ***
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Up
    Historical NEXI trend table...
    Date Alert Name Type % Chg
    Fell Below 20 DMA Bearish 0.00%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    20 DMA Support Bullish -5.85%
    Pocket Pivot Bullish Swing Setup -5.85%
    Spinning Top Other -5.85%
    Bollinger Band Squeeze Range Contraction -5.85%
    Outside Day Range Expansion -5.85%
    Up 3 Days in a Row Strength -5.85%
    Older End-of-Day Signals for NEXI ...

       Recent Intraday Alerts

    Alert Time
    20 DMA Support about 8 hours ago
    10 DMA Support about 8 hours ago
    Possible Pocket Pivot about 8 hours ago
    Fell Below 10 DMA about 9 hours ago
    Possible Inside Day about 9 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    NEXI Chart by TradingView
    Basic chart:

    Profile

    NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation (AIM) technology. The company has two product candidates in human trials, including NEXI-001 in acute myeloid leukemia, or AML; and NEXI-002 in multiple myeloma, or MM. NexImmune, Inc. was founded in 2011 and is headquartered in Gaithersburg, Maryland.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biotechnology Cancer Clinical Medicine Immunotherapy Acute Myeloid Leukemia Immunotherapies Leukemia Multiple Myeloma Immune Mediated Diseases

    Is NEXI a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Mar 7 Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Feb 6 NexImmune Announces Closing of $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
    Feb 2 NexImmune slips after securities offering
    Feb 2 NexImmune Announces $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
    Jan 9 Why JetBlue Airways Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Jan 8 Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Jan 4 Why Mobileye Global Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Dec 1 Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
    Nov 6 What's Going On With Neximmune (NEXI) Stock Monday?
    See more NEXI news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 28.6949
    52 Week Low 1.2501
    Average Volume 58,225
    200-Day Moving Average 5.35
    50-Day Moving Average 4.73
    20-Day Moving Average 3.42
    10-Day Moving Average 3.35
    Average True Range 0.39
    RSI (14) 40.48
    ADX 18.79
    +DI 21.46
    -DI 20.10
    Chandelier Exit (Long, 3 ATRs) 3.25
    Chandelier Exit (Short, 3 ATRs) 4.18
    Upper Bollinger Bands 3.80
    Lower Bollinger Band 3.04
    Percent B (%b) 0.45
    BandWidth 22.17
    MACD Line -0.40
    MACD Signal Line -0.52
    MACD Histogram 0.1212
    Fundamentals Value
    Market Cap 4.4 Million
    Num Shares 1.3 Million
    EPS -42.05
    Price-to-Earnings (P/E) Ratio -0.08
    Price-to-Sales 0.00
    Price-to-Book 1.42
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.96
    Resistance 3 (R3) 4.01 3.86 3.87
    Resistance 2 (R2) 3.86 3.71 3.84 3.83
    Resistance 1 (R1) 3.62 3.62 3.55 3.57 3.80
    Pivot Point 3.47 3.47 3.43 3.45 3.47
    Support 1 (S1) 3.23 3.32 3.16 3.19 2.96
    Support 2 (S2) 3.08 3.23 3.06 2.93
    Support 3 (S3) 2.84 3.08 2.89
    Support 4 (S4) 2.80